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Abstract 
In 1917, a food chemist named James Currie made a promising discovery: any strain of the filamentous mould 
Aspergillus niger would produce high concentrations of citric acid when grown in sugar medium. This tricarboxylic 
acid, which we now know is an intermediate of the Krebs cycle, had previously been extracted from citrus fruits for 
applications in food and beverage production. Two years after Currie’s discovery, industrial-level production using 
A. niger began, the biochemical fermentation industry started to flourish, and industrial biotechnology was born. A 
century later, citric acid production using this mould is a multi-billion dollar industry, with A. niger additionally produc-
ing a diverse range of proteins, enzymes and secondary metabolites. In this review, we assess main developments in 
the field of A. niger biology over the last 100 years and highlight scientific breakthroughs and discoveries which were 
influential for both basic and applied fungal research in and outside the A. niger community. We give special focus to 
two developments of the last decade: systems biology and genome editing. We also summarize the current interna-
tional A. niger research community, and end by speculating on the future of fundamental research on this fascinating 
fungus and its exploitation in industrial biotechnology.
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Introduction
For millennia, humanity has practiced rudimental forms 
of biotechnology: by fermenting starch and sugars pre-
sent in grains and fruits, ancient civilizations were able 
to produce bread, beer, wine, and other alcoholic bever-
ages. Prior to the late nineteenth and early twentieth cen-
tury, these processes were conducted without knowledge 
of the underlying biological events. Now, brewery and 
wine making is a well-understood, controlled industrial 
process. Similarly, in just a century, industrial biotechnol-
ogy has changed dramatically and flourished, from initial 
proof-of-principle experimentation in Erlenmeyer flasks, 
to a multibillion dollar industry producing megatons of 
useful molecules [1]. Fungal biotechnology is undoubt-
edly a major contributor and driver of this success. As 
just one example, the estimated market volume for plant-
degrading enzymes from filamentous fungi in 2016 was 
€4.7 billion, which was expected to reach up to €10 bil-
lion within the next decade [2]. In this celebratory his-
torical overview, we outline some of the crucial advances 
for the filamentous mould Aspergillus niger since the 
very first biotechnological experiments using this fungus 
100 years ago.
100 years ago: industrial biotech is born
In contrast to what most people might think, citric acid 
is not—or not anymore—isolated from citrus fruits, but 
is industrially produced by the filamentous fungus A. 
niger. The process was pioneered by James Currie, a food 
chemist, who 100  years ago published a study describ-
ing the superior properties of A. niger for the industrial 
production of the acid [3]. In particular, Currie showed 
the necessary growth medium for citric acid biosyn-
thesis, and the ability of the fungus to grow at low pH 
(2.5–3.5), while still being able to produce high amounts 
of the metabolite. Moreover, this work demonstrated 
the direct correlation between amount of substrate in 
the medium and amount of product, laying the basis for 
modern-day industrial fermentation of citric acid [3]. In 
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contrast to other species of fungi that had been reported 
to produce citric acid by 1917, every single strain of A. 
niger that Currie tested could efficiently produce this 
molecule when grown in sugar solutions. Two years later, 
the American company Pfizer made a pilot plant for bio-
chemical production of citric acid, and by the mid 1920s, 
production using A. niger fermentation far outweighed 
extraction from citrus fruits [4].
The citric acid cycle was comprehensively determined 
over the next several decades, resulting in the award of 
the Nobel Prize to Hans Krebs and Fritz Lipmann in 
1953. The first and final reaction in the cycle involves the 
formation of citrate from oxaloacetate, acetyl-CoA, and 
water, by a citrate synthase, ultimately generating chemi-
cal energy in the form of adenosine triphosphate (ATP). 
The objective of industrial microbiologists, including 
James Currie, was to exploit this cycle, and indeed many 
other metabolic pathways, to ferment useful molecules.
Although there are variations in fermentation tech-
niques, in general, industrial production of citric acid 
requires aerobic, submerged growth of A. niger in a 
sugar solution, which is usually derived from inexpensive 
sources, such as molasses, corn steep liquor, or hydro-
lysed corn starch, amongst others. After fermentation, 
A. niger is physically removed, usually by filtration, and 
citric acid is isolated by precipitation of the fermentation 
mix with calcium hydroxide (lime) to generate calcium 
citrate salt. Subsequent treatment with sulphuric acid 
yields the citric acid product.
The widespread applications of citric acid are shown by 
current figures regarding this metabolite: in 2007, world-
wide production was estimated at 1.6 million tons, with 
an estimated value of $2.6 billion in 2014 and predicted 
to rise to $3.6 billion by 2020 [1, 5]. As a weak acid, it 
can be used as an antioxidant, preservative, acidulant, 
pH-regulator, or flavour in food and beverages, as well as 
comparable applications in the pharmaceutical and cos-
metics industries. Citric acid is currently predominantly 
produced in China, which accounts for approximately 
60% of global production [1]. However, A. niger industrial 
applications are not just limited to the production of cit-
ric acid; as a prolific secretor, numerous industrially rel-
evant enzymes and other molecules are produced by this 
fungus. Below, we summarize some of the key develop-
ments in the field over the last century.
A historical snapshot of A. niger research
The fundamental and applied scientific discoveries using 
A. niger over the last 100 years are extremely diverse. As 
Currie wrote in 1917: ‘Few concise statements can be 
made concerning the metabolism of an organism capa-
ble of producing such a variety of chemical transforma-
tions as Aspergillus niger’ [3]. Nevertheless, some trends 
regarding the history of the A. niger research field can, 
in general terms, be deciphered. We conducted a survey 
of the A. niger literature since Currie’s seminal study by 
interrogating the PubMed database [6] for any publica-
tion containing ‘Aspergillus niger’ in the title. The result-
ing articles (> 3000, see Additional file 1: Table S1) were 
divided into five 20-year periods based on their publi-
cation date, and the 20 most common words from the 
available titles during each time period were visualized 
as word clouds (Fig. 1). Although querying the PubMed 
database for ‘Aspergillus niger’ in abstract and keywords 
resulted in more returned manuscripts (> 8700 hits), we 
decided to limit our word-cloud analysis specifically to 
titles. We applied this restriction as searching among 
manuscript abstracts returned a majority of hits where 
researchers used A. niger in simple growth assays to vali-
date efficacy of putative antifungals. While of interest, 
these research efforts (which were extremely common 
from 1977 onwards) are not, specifically, interested in A. 
niger biology per se.
Our analysis of 100 years of A. niger publications indi-
cated, unsurprisingly, that ‘citric acid’ and ‘fermentation’ 
were amongst the most common returned words in titles 
from every period (Fig. 1). Clearly, Currie’s discovery of 
conditions for maximizing citric acid production [3] was 
indeed a biotechnological revolution, and one that would 
constitute a major focus of research over the next cen-
tury. Indeed, A. niger research has rapidly grown over the 
past 40 years (Fig. 2). Although by no means exhaustive, 
distinct historical trends become apparent from our anal-
ysis (Fig. 1).
The foundations of A. niger research
From the period 1937–1956, A. niger researchers were 
predominantly concerned with the impact of micro/
macro nutrients in cultivation media and growth param-
eters for optimized citric acid fermentation (Fig.  1, [7, 
8]). Most studies specifically utilized submerged culture, 
which obviously reflects the need to control growth, 
morphology, and, ultimately, citric acid production dur-
ing fermentation (Additional file  1: Table  S1 and [9]). 
After the award of Hermann Muller’s Nobel Prize in 
1946 for work on mutations via X-ray irradiation, the 
late 1940s and early 1950s saw the first mutagenesis stud-
ies in biological sciences deployed by the A. niger com-
munity in order to generate strains with improved citric 
acid yields [10]. The number of UV, X-ray, and chemical 
mutagenesis efforts increased from 1957 to 1976, with 
most focusing on enhancing citric acid production (e.g. 
[11] and Fig. 1).
Notably, the period from 1957 to 1976 saw a paradigm 
shift amongst the A. niger biotechnological research 
community, with the widespread realization that this 
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fungus was not exclusively applicable for citric acid fer-
mentation, but was also a prolific producer of useful 
enzymes (Fig. 1). A rapid growth of studies, facilitated by 
technological advances in chromatography, conducted 
purification and enzymatic analysis of diverse range of 
A. niger proteins, including various oxidases, dehydro-
genases, hydrolases, cellulases, and pectinases, amongst 
others (Fig. 1, [12–16]). These discoveries were not only 
useful for industrial production of enzymes, but also sig-
nificantly contributed to fundamental understanding of 
enzyme function. One notable pair of isoenzymes first 
purified in the late 1960s and early 1970s was A. niger glu-
coamylases [17, 18]. These discoveries would eventually 
lead to the widespread application of A. niger glucoam-
ylases in the fermentation, food, and beverage industries, 
where these enzymes catalyse the saccharification of 
partially processed starch to glucose. Indeed, glucoam-
ylase research features heavily in publications from 1977 
to present day (Fig.  1). Interestingly, a recent business 
report showed that the glycoamylase market played a sig-
nificant role for the success of leading multinational bio-
tech companies, including AB Enzymes, Amano Enzyme, 
DSM, Genencor, Novozymes, and Verenium [19].
Outside the field of industrial microbiology, there was 
early interest in the 1970s in the clinical spectrum of dis-
ease caused by the Aspergillus genus, with authors first 
associating A. niger spore inhalation with the onset of 
asthma [20]. The serious threat of fungal disease both 
with regards to human health and crop destruction is 
now much better understood [21]. Indeed, fungal infec-
tions affect and estimated 1.2  billion people globally, 
resulting in approximately 1.5–2  million deaths per 
year. As a consequence of limited antifungal therapeutic 
options and timely diagnostics, mortality rates can be 
extremely high, reaching up to 90% in case of immuno-
compromised patient and/or drug-resistant strains caus-
ing invasive aspergillosis or other systemic mycoses [2]. 
Indeed, the fungicide market to control fungal growth in 
Fig. 1 A historical snapshot of A. niger research. The PubMed database was interrogated for any publication that contained ‘Aspergillus niger’ in the 
title. Publication titles were assigned to periods of 20 years. As 1917–1936 only returned 7 manuscripts, this period was omitted. Word clouds were 
generated online (https://worditout.com/word-cloud/create), and the top 20 words, not including ‘Aspergillus niger’ or non-technical terms (e.g. 
prepositions etc.), are depicted. Size of each word is proportional to relative frequency amongst all the titles in that period. Retrieved articles for 
each period: 112 (1937–1956), 481 (1957–1976), 642 (1977–1996), 1789 (1997–2017)
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agriculture and medicine was estimated at €10 billion in 
2014 [2].
The dawn of molecular biology and the first A. niger 
transformations
A revolution in biotechnology occurred between 1977 
and 1996 with the advent of molecular biology. These 
technological developments and rapid discoveries in 
A. niger molecular biology and genetics are reflected by 
a heavy community-wide focus on genes, cloning, and 
sequence analyses (Fig. 1). Arguably the most fundamen-
tal technique for molecular analyses of any organism is 
the ability to transform exogenous DNA into target cells 
and integrate them into recipient genomes. In a semi-
nal study, Peter Punt and Cees van den Hondel utilised 
a hygromycin resistance gene from Escherichia coli, 
encoding a phosphotransferase, as a dominant selecta-
ble marker in A. niger and A. nidulans [22]. In addition 
to becoming one of the most commonly used domi-
nant selectable markers in fungal transformation, this 
work pioneered plasmid mediated cassette integration 
in filamentous fungal genomes using the vector pAN7-
1. Moreover, the authors further validated the use of the 
A. nidulans glyceraldehyde-3-phosphate dehydrogenase 
(gpd) promoter, and the trpC terminator. In an alterna-
tive approach, other studies optimized a homologous 
transformation system using the orotidine 5′-phosphate 
decarboxylase gene pyrG [23, 24]. This recyclable auxo-
trophic marker would ultimately facilitate several hun-
dred studies of A. niger gene function, and is still used 
today, most obviously as a transformation system, but 
also as a convenient locus for cassette integration during 
heterologous and homologous gene expression studies 
[25].
Introduction of such molecular studies began to ena-
ble industrial microbiologists to obviate a diverse range 
of technical challenges when working with filamentous 
fungi. As just one example, heterologous expression of 
a porcine pancreatic phospholipase gene in A. niger by 
the lab of David Archer initially did not produce detect-
able protein, which was revealed to be due to degrada-
tion of this enzyme by intracellular and extracellular A. 
niger proteases [26]. The authors therefore used PCR and 
restriction endonuclease cloning approaches, which were 
cutting-edge at the time (and indeed still practiced in 
most molecular laboratories today), to express a prophos-
pholipase-glucoamylase fusion protein in a protease-defi-
cient A. niger strain. This recombinant approach enabled 
secreted concentrations of fusion protein at 10 μg/mL.
The utilisation for A. niger for production of a diverse 
range of enzymes also continued between 1977 and 1996, 
as exemplified by numerous efforts during this period for 
the fermentation and purification of proteases (Fig.  1). 
Fungal proteases are active at a broad range of abiotic 
conditions (e.g. pH, temperature) and consequently are 
now applied in food, laundry detergent, and pharmaceu-
tical processes, amongst others (reviewed in [27]).
Fig. 2 Total number or paper published on PubMed for selected filamentous fungi over the last 40 years. The literature database was queried for 
title, abstract and keywords with the full species name (in brackets: total results for 1978–2017). As comparison: Saccharomyces cerevisiae gave more 
than 110,000 hits with around 2000–4000 hits/year over the last 25 years (Additional file 2: Table s2)
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The last 20 years: rapid developments in the A. niger 
research field
The development of the A. niger molecular toolkit accel-
erated from 1997 to 2017. Notable milestones include 
the generation of nonhomologous end joining (NHEJ) 
mutants in a collaborative effort between our lab and the 
lab of Arthur Ram [28], which enable increased target-
ing efficiency of exogenous DNA cassettes with recipi-
ent genomes during fungal transformation. Filamentous 
fungal NHEJ mutants were first described in the model 
organism Neurospora crassa in 2004 [29] and the drastic 
increase in cassette targeting rates (up to 100% of trans-
formed fungal cells) led to the rapid application of this 
tool by researchers in the Aspergillus genus, including A. 
niger [28, 30].
The application of A. niger as a cell factory for useful 
enzymes continued to rapidly expand between 1997 and 
2017 (Fig. 1). Phytases, for example, were first marketed 
in 1991, and are used to improve the nutritional content 
of animal feed by generating inorganic phosphorus from 
phytic acid, which is the major form of organic phospho-
rus in plant seed [31]. The biotechnological production 
market of phytases is estimated to be over €150 million 
per year, with A. niger one of the most commonly used 
microorganisms [32].
In addition to homologous or heterologous produc-
tion of single industrially relevant proteins, A. niger and 
other Aspergilli have been increasingly harnessed for 
synthesis of diverse enzyme mixtures over the last dec-
ade. One critical application of such enzyme cocktails is 
the degradation of plant polysaccharides, whereby cellu-
lose, hemicellulose, and pectin can be broken down into 
oligosaccharides and monosaccharides and the number 
of A. niger genes predicted to encode proteins capable of 
plant biomass degradation is over 170 [33]. Moreover, the 
transcription factors that regulate these genes are being 
rapidly elucidated, for example the amylolytic regulator 
AmyR (the first regulator identified in A. niger) [34], pec-
tinolytic regulator RhaR [35], and hemi-cellulolytic regu-
lator XlnR [36, 37], amongst several others (reviewed in 
[33]). Integrating knowledge of transcription factor net-
works with a comprehensive understanding of upstream 
molecular sensors and signalling cascades may enable 
the engineering of A. niger isolates with increased plant 
biomass degradation capabilities. The impact of such 
microbial cell factories will enable the renewable gen-
eration of starting material for production of biofuels 
and other industrial processes from plant material. Con-
sequently, future A. niger strains may enable transition 
from our current fossil-based economy to a bio-based 
economy, whereby future fuel is generated from renew-
able resources.
In general, between 1996 and present day, much pro-
gress has been made for enzyme expression using A. 
niger, with higher titres of secreted proteins increas-
ingly possible (e.g.  30  g/L for glucoamylase  is com-
mon) (reviewed in [38, 39]). These advances have been 
achieved by several now routine approaches, including 
codon optimisation of non-fungal genes, and, in some 
instances, use of a fusion carrier protein [38]. However, 
a significant bottleneck that inhibits maximum yield of 
secreted proteins is an incomplete understanding of fila-
mentous fungal secretion. In the model postulated by 
Taheri-Talesh using A. nidulans [40], secretion and polar 
growth are physically coupled at the hyphal tip (first 
showed in A. niger by Han Wösten et  al. in 1991 [41]). 
Currently, however, the underlying mechanisms of fun-
gal protein secretion are not understood as an integrated 
system, with numerous outstanding questions hamper-
ing rational strain engineering. For example, by investi-
gating secretome in concentric zones of A. niger colonies 
it has been observed that secretion and growth can be 
uncoupled [42]. How can this phenomenon be further 
exploited to further increase secretion yields without 
affecting hyphal tip growth? What molecular signals and 
regulators control and limit protein secretion? We specu-
late that delivering a systems-level understanding of the 
molecular and cellular mechanisms that underpin fungal 
secretion will one of the major research goals over the 
next 20 years.
Several studies over the past decade have interrogated 
the effect of filamentous microscopic and macroscopic 
morphologies on secretion during industrial applica-
tions. For example, A. niger hyperbranching phenotypes 
have been generated to study the underlying morphoge-
netic gene network controlling polar growth, and, else-
where, secretion or the macromorphology of A. niger has 
been modified by the addition of micro-particles to sub-
merged media [43, 44]. These genetic or microbiological 
approaches offer increasingly accurate control of hyphal 
branch length, enabling optimization of fermentation cul-
ture viscosity, and also minimising A. niger sensitivity to 
shear stress. Intriguingly, a promising avenue of research 
for maximising industrial protein titres comes from 
analyses of secretion in A. oryzae, which has conclusively 
demonstrated that secretion also occurs at septal junc-
tions [45, 46]. This might conceivably be harnessed by 
industrial microbiologists as a secondary secretion route 
to maximize secretion of useful enzymes in Aspergillus 
species, including A. niger. Another level of complex-
ity behind A. niger secretion was uncovered by pioneer-
ing studies of the labs of Han Wösten, Arthur Ram and 
Cees van den Hondel: the discovery of heterogeneity of 
fungal secretion on the cell [47], hyphal [48] and colony 
level [49]. This work laid the conceptual framework for 
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follow-up studies on population heterogeneity in model 
and industrial Aspergilli [50–52].
Outside the field of industrial microbiology, one 
alarming observation is that the last century of A. niger 
research spans the discovery of penicillin, for which Alex-
ander Fleming, Ernst Chain, and Howard Florey were 
awarded the Nobel Prize in 1945, and the subsequent 
global emergence of drug resistant pathogenic microbes. 
Currently, as the incidence of drug resistance increases, 
the number of chemical compounds approved for use 
in agriculture or the clinic is decreasing [53]. Given that 
microbial secondary metabolites are a rich source of 
novel bioactive molecules [54], the focus of our lab and 
others over the last 5 years has been to establish A. niger 
as an industrial platform strain for drug discovery and 
natural product production. This objective is based on 
the assumption that the high intracellular glycolytic flux 
towards citric acid (and amino acids derived thereof ) 
can be exploited and redirected into non-ribosomal pep-
tide synthesis. Recent work has demonstrated we could 
indeed genetically engineer A. niger to heterologously 
overexpress a non-ribosomal peptide synthetase (NRPS) 
from Fusarium spp. in several g/L amounts [55]. This 
proof of principle experiment, which utilized the highly 
optimised and titratable synthetic Tet-on gene switch 
[25] to produce the antimicrobial cyclohexadepsipeptide 
enniatin, will hopefully pave the way for future produc-
tion of multiple secondary metabolites. Indeed, more 
recently, we could generate A. niger isolates expressing 
truncated enniatin NRPS enzymes or with key domains 
positionally exchanged, to generate new-to-nature mol-
ecules at high titers (e.g. 1.3 g/L) [56]. Excitingly, some of 
these new molecules demonstrated enhanced antipara-
sitic activity when compared to existing drugs [56]. Given 
the high diversity of fungal secondary metabolite genes, 
and their frequent transcriptional silence under labora-
tory conditions, expression using A. niger as a heterolo-
gous host, and the molecular approaches validated by 
these two studies, hold great promise for discovery of 
new chemical leads for compound development in agri-
culture and the pharmaceutical industry. This is further 
supported by recent work that has applied viral DNA 
sequences (encoding, for example, the 2A peptide), in 
order to enable polycistronic gene expression in A. niger 
[57, 58]. These studies provide proof of principle that 
complex secondary metabolites, which require multiple 
enzymes for their biosynthesis, can be produced by poly-
cistronic gene switches in A. niger.
To summarize, one century after James Currie’s 
ground-breaking work on biotechnological citric acid 
production, his assessment still generally holds true: it 
is difficult to make comprehensive statements about the 
production capabilities of A. niger owing to its metabolic 
versatility, and the many as-yet undisclosed metabolic 
pathways. However, the dawn of molecular biology, and 
recent breakthroughs in synthetic biology for A. niger, 
have ultimately engineered a multipurpose cell fac-
tory out of a citric acid producer. A. niger is the most 
versatile filamentous fungal platform strain which can 
now be exploited to produce acids, proteins, enzymes, 
and medicinal drugs (Table  1). Two developments that 
occurred over the last decade promise to open entirely 
new avenues of scientific study using A. niger: genome 
sequencing and the introduction of genome editing. The 
following sections look at these two developments in 
more detail.
2007: the genome sequence of Aspergillus niger is 
released
The first filamentous fungal genome to be published was 
that of the model ascomycete Neurospora crassa in 2003, 
160  years after the discovery of this species in a Paris 
bakery [59]. Several hallmarks of fungal genomes were 
reported in this ground-breaking draft, in particular (1) 
contiguous gene clusters for secondary metabolite bio-
synthesis; (2) defence from parasitic mobile genetic ele-
ments via repeat induced point mutation; (3) variations 
in telomeric gene content when compared to telomere-
distal chromosome regions; (4) and the presence of two 
putative RNA silencing pathways, amongst others [59]. 
It was in this context that the first A. niger genome was 
released in 2007 [60], by which time three Aspergillus 
genomes were also publicly available: A. nidulans [61], A. 
oryzae [62], and A. fumigatus [63]. These genomes were 
representative of the broad utilities and challenges posed 
by the Aspergillus genus: model organism, food producer, 
and human-infecting fungus, respectively. The publica-
tion of the A. niger genome was thus the first, and, argu-
ably, the most important, industrial Aspergillus genome 
to be sequenced. For this draft assembly, Herman Pel 
and colleagues used the enzyme producing isolate CBS 
513.88, which is a derivative of A. niger NRRL 3122, a 
strain generated by classical mutagenesis for glucoamyl-
ase A production [60]. This was therefore the first global 
analyses of the A. niger genome repertoire that had been 
harnessed in industrial applications for many decades, 
and remains one of most comprehensively annotated 
genome resource for the A. niger community.
Numerous explanations of the suitability of A. niger 
for industrial applications were identified from the esti-
mated 34  Mb genome, with its estimated 14,165 cod-
ing genes. For example, the authors predicted various 
gene duplication events that may have led to expansion 
of genes necessary for the production of the citrate pre-
cursor oxaloacetate [60], an observation that explains 
the remarkable capability for citric acid production by 
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A. niger. Indeed, this hypothesis has been supported by a 
very recent comprehensive comparative genomic analysis 
of black aspergilli in a community effort led by Ronald de 
Vries [64], which was published exactly 10 years after the 
public release of A. niger genome sequence. With regards 
to the nutritional versatility of A. niger, genes encoding 
putative nutrient transporters were enriched in A. niger 
when compared to A. nidulans or A. fumigatus. These 
genes were presumed to enable uptake or sensing of 
diverse carbon and nitrogen sources [60].
In the context of novel bioactive molecule discov-
ery, numerous putative secondary metabolite loci were 
identified based on the presence of either a polyketide 
synthase (PKS) or NRPS encoding gene [60]. Intrigu-
ingly, the vast majority of these clusters lacked either an 
experimentally verified or predicted biosynthetic prod-
uct, thus indicating the potential for novel pharmaceu-
tical discovery using A. niger and other Aspergilli [65, 
66]. Indeed, these observations have been corroborated 
by recent comparative genomic analyses of the Aspergil-
lus genus [64], which indicate that A. niger CBS 513.88 
has 57 predicted secondary metabolite clusters, whilst 
another study predicts 81 secondary metabolite clusters 
[67], the highest of all Aspergillus genomes analyzed so 
far. The latter study follows an extensive manual anno-
tation approach and likely more precisely predicts the 
actual secondary metabolite repertoire of A. niger. Taken 
together, these exemplar discoveries highlight how the A. 
niger draft genome provided the first global explanations 
for the many industrially relevant phenotypes of this 
organism, and facilitated a new era of forward genetics in 
this species. Moreover, in the immediate aftermath of this 
revolutionary resource for the A. niger community, com-
parative genomic analyses amongst the aspergilli would 
also redefine species concepts [68], interrogate sexual 
compatibility [60], and the nature of fungal virulence 
[69], amongst other critical developments (reviewed in 
[70]).
Table 1 Selection of (multi)national companies exploiting A. niger for the production of important industrial com-
pounds. Modified after Fiedler et al. 2013 [79]
Company Headquarter Products
Adcuram Germany Citric acid
AB Enzymes Germany Glucoamylase
ADM USA Citric acid
Agennix Germany Lactoferrin
Amano Enzyme Co. Ltd. Japan β-Galactosidase, Glucoamylase, Glucose oxidase, Hemicellulase, Proteases
Anhui BBCA Biochemical China Citric acid
BASF Germany Hemicellulase, Phytase
Biocon India Cellulase, Hemicellulase, Pectinase
Cangzhou Kangzhuang Chemical China Glucoamylase
Cargill USA Citric acid
Christian Hansen Denmark Chymosin
COFCO China Citric acid
DSM The Netherlands Arabinase, Asparaginase, Catalase, Cellulase, β-Galactosidase, Glucoamylase, Glucose oxidase, 
Hemicellulase, Lactoferrin, Lipase, Pectinase, Phytase, Proteases, Xylanase
Dupont IB The Netherlands Catalase, β-Galactosidase, Glucoamylase, Glucose oxidase, Hemicellulase, Lipase, Pectinase
Dyadic USA Cellulase, Glucoamylase, Glucose oxidase
Gadot Biochemical Industries Israel Citric acid
Genencor INT USA Cellulase, Hemicellulase, β-Galactosidase
Haihang Industry China Cellulase
Iwata Chemical Co. Ltd Japan Citric acid
Jungbunzlauer Switzerland Citric acid
Mitsubishi Foods Co. Ltd. Japan Proteases
Megazyme USA Catalase, Inulinase, Glucosidase
Novozymes Denmark Asparaginase, Catalase, β-Galactosidase, Glucoamylase, Hemicellulase, Lipase, Pectinase, Phytase, 
Proteases
Shandong Longda Bio-Products China Glucoamylase, Pectinase
Shin Nihon Chemical Co. Ltd. Japan Arabinase, Catalase, Cellulase, β-Galactosidase, Hemicellulase, Proteases
Tate & Lyle UK Citric acid
Verenium USA Glucoamylase, Proteases
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DNA sequencing technology and analyses are now 
sufficiently accurate and high throughput to be rou-
tinely applied to answer a diverse range of fundamental 
research questions in A. niger. One recent and notable 
example is the so called bulk segregant analyses devel-
oped by Arthur Ram’s lab, which was used to identify a 
single nucleotide polymorphism (SNP) responsible for a 
nonacidifying phenotype of a UV-mutated isolate [71]. 
In the bulk segregant approach, the A. niger parasexual 
cycle is used to cross a wild-type strain with a mutant 
of interest, and haploid segregants with the phenotype 
of interest are identified. Subsequently, DNA from these 
segregants and parental isolates are sequenced to identify 
SNPs. Amongst these isolates, the SNP that is conserved 
in all segregants, yet absent in the wild-type isolate, is 
responsible for the mutant phenotype. Fascinatingly, they 
demonstrated that the nonacidifying mutant phenotype 
was due to a lack of citric acid secretion, and the SNP 
was located in the gene encoding the putative methyl-
transferase LaeA [71]. This protein is a component of the 
velvet complex, which regulates light responses, develop-
ment, and secondary metabolism in Aspergilli [72]. Con-
sequently, these systems genetics approaches have shed 
light on the link between LaeA, citric acid, and secondary 
metabolism in A. niger.
Analyses of A. niger genome sequences identify several 
challenges that are yet to be comprehensively resolved
Several pitfalls to industrial applications of A. niger were 
also highlighted from the publication of the draft genome 
[60]. Unsurprisingly, numerous predicted protease 
encoding genes were identified, many of which contained 
a secretion peptide, which undoubtedly pose a significant 
challenge to industrial protein production. Additionally, 
gene clusters predicted to biosynthesize the mycotoxins 
fumonisin and ochratoxin A were present in CBS 513.88. 
Subsequent metabolomic analyses led by Jens Frisvad 
and his colleagues suggest up to 10% of industrially used 
A. niger isolates are able to produce these potential car-
cinogens [73]. In addition to potential issues with toxic-
ity, production of unwanted secondary metabolites might 
confound production efforts of heterologous metabolites 
or new-to-nature compounds, as these molecules will 
be produced under similar conditions, and will likely be 
co-extracted during proof-of-concept of scale-up stages. 
However, with genome editing technology (see below), 
it should be possible to tackle this problem by removing 
mycotoxin clusters [2].
A more general problem that became apparent from 
the A. niger genome sequence, however, was that func-
tional predictions were only possible for approximately 
half of the putative 14,165 putative open reading frames 
[60]. Subsequent release of additional A. niger genomes 
[74, 75] and the continued improvement and refinement 
of online genome databases and analyses portals [76–80] 
have not drastically increased rates of gene functional 
annotation. Indeed, genome mining of the acidogenic 
isolate ATCC 1015 [74] using the publicly available analy-
ses portal FungiDB [79] indicates that 4491 (approxi-
mately 41%) of predicted genes encode products that are 
annotated as a ‘hypothetical protein’, which also lack any 
functional prediction based on Gene Ontology (GO) or 
Interpro Domains.
This genomic ‘black box’ presents several challenges for 
systems level understanding of A. niger and rational strain 
engineering for industrial applications. Firstly, while sev-
eral thousand ‘hypothetical’ genes are transcriptionally 
active during a diverse range of experimental conditions, 
many of which model industrial processes [79], the incen-
tive to study these genes using time and labour-intensive 
loss-of-function approaches is very low. This is further 
complicated by functional redundancy, where deletion 
of a single gene has no measurable impact. This problem 
has been partially obviated by continued molecular tool 
development in A. niger, as highly optimized, titratable, 
and inducible/repressible promoters have been devel-
oped [81]. These molecular tools enable expression of a 
gene above the native levels, leading to measurable phe-
notypic effects in so called ‘gain-of-function’ approaches, 
with the added advantage that it is possible to function-
ally characterize essential genes. However, these strate-
gies are unlikely to have the necessary throughput for 
functional characterization of several thousand genes.
Secondly, assigning functional prediction to the 
genomic ‘black box’ using gene orthology is also prob-
lematic, as model (or reference) organisms can be mis-
leading. Indeed, inferring function from unicellular 
yeasts, such as Saccharomyces cerevisiae, or other Asper-
gilli, such as A. nidulans, is at best advisory, and at worst 
misleading, with genes and encoded products playing 
different roles between organisms [2, 82]. Recent appli-
cations of genome editing in filamentous fungi arguably 
hold the greatest promise for rapid gene functional char-
acterization in A. niger [83, 84], with the potential to lead 
to comprehensive, systems level understanding of this 
organism, or to engineer new synthetic or semi-synthetic 
derivatives for highly optimized industrial applications.
A new era: genome editing with CRISPR/Cas
Actually described 30  years ago in 1987 [85], CRISPR 
(clustered regularly interspaced palindromic repeats) 
elements have been universally exploited along with 
associated endonucleases (for example proteins of the 
Cas family) for about 5 years. Early DNA sequencing of 
bacterial genome revealed short repetitive sequences 
with unknown functions in E. coli [85], which were 
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then discovered across many bacterial species and two 
decades later revealed as an adaptive defence mecha-
nism against bacteriophages [86]. While studying ways 
to reduce susceptibility of starter cultures for yoghurt 
production against phages, industrial biotechnologists 
observed that cultures previously exposed to a virus 
where resistant upon a second encounter with the same 
[86]—the reason being the specific recognition, double-
strand cut and inactivation of the invading DNA by the 
CRISPR/Cas9 system. In a seminal 2012 paper, it was 
shown that the system is programmable to cut any DNA 
sequence with high specificity [87], which generated a 
watershed momentum, given the ability of the endonu-
clease to retain its activity in many different organisms 
(fungi, insects, mice, humans, plants etc.). The use of the 
genome editing technology in filamentous fungi has been 
recently reviewed [88]. While delivery of DNA encod-
ing the components of the system (endonuclease, guide 
RNA), or in vitro generated components themselves, into 
the fungal cell remains a challenge due to the fungal cell 
wall, and still requires common protocols as protoplast-
ing, different strategies have been developed to increase 
efficiency in species such as A. niger and other Aspergil-
lus spp., Alternaria alternata, Coprinopsis cinerea, Usti-
lago maydis, Trichoderma reesei, Neurospora crassa, 
Penicillium chrysogenum, Myceliophthora thermophila, 
Beauveria brassiana (reviewed in [88]). These strategies 
include the use of efficient promoters like trpC, gpdA or 
RNA polymerase III promoters like U6 for in vivo expres-
sion of endonuclease and/or gRNA, codon optimization 
of Cas9, transient expression of endonuclease, integra-
tion of endonuclease into the host genome, delivery of 
in vitro synthesized gRNA or purified endonuclease, and 
others. Also, considerations concerning the use of appro-
priate markers (following transformation of CRISPR/Cas 
components or genome editing) and lethal or unwanted 
(e.g. off-target) effects of the endonuclease have been 
addressed in filamentous fungi. For the latter, specific-
ity of genome editing can be increased by (1) favouring 
host’s homology-directed repair (HDR) over non-homol-
ogous end-joining (NHEJ) pathway following DNA cut, 
or (2) generating DNA double-strand breaks with long 
overhangs by using either a modified Cas9 (nickase 
Cas9—a.k.a. nCas9—able to cut only one DNA strand 
and thus following duplexing with two distinct gRNA 
generating long “sticky ends”) [89].
With the proper strategy, CRISPR/Cas technology 
looks like a spider able to catch a couple of flies; indeed, 
a broad spectrum of opportunities arises for strain engi-
neering. One recent example illustrates the reach of 
the technology when applied to A. niger and other fila-
mentous fungi. Kuivanen et  al. [90] used CRISPR/Cas 
technology to delete multiple genes in A. niger for the 
biotechnological production of the platform chemical 
galactaric acid. Derived from d-galacturonic acid, the 
main component of the natural polymer pectin, galac-
taric acid is used as precursor for Nylon and in skin-care 
cosmetics [90]. Although A. niger can hydrolyze pectin, 
d-galacturonic acid is also a precursor for the fungal 
galacturonic acid pathway, and galactaric acid can be cat-
abolized by an unknown pathway. The authors deleted 
seven genes involved in catabolism of d-galacturonic acid 
and galactaric acid in A. niger using a strategy involving 
in  vitro synthesized gRNA and plasmid-encoded Cas9. 
With such an engineered A. niger strain, the authors 
showed the digestion of pectin-rich biomass into galac-
taric acid in a single process [90].
The Aspergillus niger community as of today
In an effort to map the landscape of international 
research groups currently working on A. niger, we 
retrieved all PubMed articles with ‘Aspergillus niger’ 
in title, abstract, and keywords published during the 
last 5  years (2013–2017), resulting in 2068 hits (Addi-
tional file 3: Table S3). Members of the community were 
defined by having authored at least 5 articles over the 
last 5  years. This list of researchers was then manually 
curated to highlight group leaders/PIs, and collaboration 
among research groups (as determined by at least one 
co-authorship). We focused on this relative short time 
span to ensure mapping of researchers actively work-
ing on A. niger, and included abstract and keywords in 
the search filter to expand the results to the community 
of those scientists not only studying A. niger biology, 
but also investigating the fungus in other relevant areas 
(e.g. bioremediation, geomicrobiology, pathogenicity, 
toxin production and food safety, agricultural microbiol-
ogy). Based on previously reported information [91–93] 
we also compiled a list of (multinational) companies 
using A. niger as a workhorse for the production of citric 
acid and enzymes (Table 1). Our mapping of both basic 
and applied research on A. niger (Fig. 3, Table 1) shows 
that the community is diverse and geographically dis-
persed, yet (at least for the basic research community) 
well-connected.
Future challenges for the A. niger community
This historical overview has covered some of the sci-
entific trends and key discoveries that have occurred in 
the field of A. niger biotechnology. Clearly, there are a 
diverse range of other industrially relevant fungi and bac-
teria that have also undergone revolutionary advances 
since their first use by early industrial microbiologists 
in the late nineteenth and early twentieth centuries. 
What does the future of industrial biotechnology hold 
for A. niger, and other microbial cell factories? In an 
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attempt to answer this question, we generated predic-
tions for common research themes and topics over the 
next 20 years of A. niger research (Fig. 4). This specula-
tion indicated a hypothesized future focus on synthetic 
biology (including generation of mycotoxin-free isolates), 
network analysis (including genomics, gene expression 
and metabolomics), increased applications of co-cultiva-
tion technology and CRISPR-Cas9 genome editing, and 
a continued focus on secondary metabolism, fermenta-
tion, citric acid production, enzymes, and glucoamylase 
research (Fig. 4).
In general, three key components are becoming 
increasingly available in the biotechnologist’s toolbox; 
(1) publicly available and well-annotated genome data for 
several A. niger strains, and open-source bioinformatic 
pipelines that enable sophisticated comparative genomic 
and other analyses by non-coders; (2) guideline cultiva-
tion protocols with engineered macroscopic morpholo-
gies of A. niger, which facilitate improved product titres; 
(3) a versatile suite of molecular techniques for high-
throughput gene functional analyses, including genome 
editing. What more has to come to fully understand and 
optimally exploit A. niger? In our opinion, the following 
outstanding questions need to be addressed by the com-
munity in the near future:
 1. How can community efforts maintain and increase 
the quality and usability (from data deposition to 
analysis) of fungal datasets in light of the increasing 
amount of omics and literature data generated? How 
Fig. 3 The A. niger research community is diverse and well-connected. Network of the community of researchers investigating A. niger biology or 
using the fungus as model organism based on our literature survey. Articles with ‘Aspergillus niger’ in title, abstract or keywords published in 2013–
2017 were retrieved from PubMed. Scientists with at least 5 last (co-)authorships were selected (Additional file 3: Table 3). Size of circles roughly 
indicates number of published articles. Connections indicate collaborations as indicated by at least one co-authorship. Scientists are located mainly 
in Europe, followed by China, South America, North America, and India. The position of the circles is arbitrary. Please note that some connections/
collaborations might be missing due to the stringency of our PubMed search
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can we verify the accuracy of predictive algorithms 
to assign function to hypothetical genes?
 2. How can we solve the “hypothetical protein prob-
lem”, and how can we assign function to those puta-
tive proteins? What is the best and easiest way to 
integrate genome, transcriptome, proteome, and 
metabolome data for powerful comparative omics 
approaches?
 3. How can we generate accurate genome-wide meta-
bolic networks that also are integrated with other 
omics data?
 4. How can miniaturised cultivation in microtiter plate 
(or smaller) size be adapted for A. niger and other 
filamentous fungi for high-throughput screenings?
 5. How can cell heterogeneity be investigated, so that 
variations in metabolism and gene-expression are 
not averaged over a whole colony or mycelium, 
and which new tools will foster these single-cell 
approaches?
 6. How can stable and reproducible growth of A. niger 
in mixed cultures be achieved, both in academic 
research (e.g. to investigate activation of secondary 
metabolism) and industrial processes (e.g. for effi-
cient enzyme production)? Which co-cultivation 
approaches and tools for the current paradigmatic 
shift in microbial cultivation [94] can be specifically 
adapted/developed for A. niger and other filamen-
tous fungi?
 7. Would concerted efforts to construct a genome-
wide deletion and/or overexpression library of A. 
niger, similar to that existing for S. cerevisiae [95], 
N. crassa [96] and Schizosaccharomyces pombe [97], 
be sufficiently helpful for the community to warrant 
the substantial investment of research funds and 
resources?
 8. How can a minimal A. niger genome be defined, and 
with which approach should it be generated? Which 
secondary metabolite clusters should be included or 
omitted?
 9. Which synthetic biology tools to regulate different 
metabolic pathways in parallel can be developed or 
implemented, e.g. for the construction of genetic 
circuits to optimize metabolic fluxes for efficient 
production of enzymes, organic acids, or secondary 
metabolites?
 10. Can A. niger, or other filamentous fungi, be exploited 
for “space biotechnological” purposes, as essential 
companions of astronauts for the autonomous pro-
duction of food, enzymes, antibiotics, or for use in 
terraforming efforts?
Conclusion
Given the tremendous advances in the knowledge of A. 
niger biology over the last century, and the concomitant 
development of bioinformatics, cultivation, and molecu-
lar tools which are now at disposal of the community, this 
industrial fungus has the potential to remain one of the 
most versatile fungal platform microorganism. A. niger 
offers a chassis for products which cannot be produced 
in easier to handle bacterial systems, and it is able to 
produce not only proteins and enzymes at high concen-
trations, but also pharmaceuticals which are beneficial 
for human and animal health. Indeed, we predict that 
A. niger will be one of the key organisms involved in the 
next industrial revolution: the change from a fossil-based 
economy to a bio-economy. At this pace, we are excited 
to witness what the future will bring.
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